PCM
BLND icon

Pathway Capital Management’s Blend Labs BLND Stock Holding History

Pathway Capital Management’s Portfolio BLND Stock Details BLND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+214,209
New +$342K 1.53% 4

Other funds holding BLND

HIM
Haveli Investment Management Austin, Texas $180M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $552M AUM
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WI
Whitebark Investors Incline Village, Nevada $129M AUM 26.3% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Pathway Capital Management's BLND Position: Q2 2026 in Review

Pathway Capital Management opened a new position in Blend Labs (BLND) in Q2 2026: 214,209 shares worth $366K. The stake represents 1.53% of the portfolio and ranks #4 among its holdings.

184 funds tracked by Wall St. Rank hold BLND as of Q2 2026.

  • Pathway Capital Management held 214,209 shares of Blend Labs worth $366K as of Q2 2026.
  • Blend Labs was a new Pathway Capital Management position in Q2 2026.
  • Blend Labs made up 1.53% of Pathway Capital Management's portfolio in Q2 2026, its #4 holding.
  • 184 funds tracked by Wall St. Rank held Blend Labs as of Q2 2026.

Based on Pathway Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.